Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | UBE2D3 | P61077 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
| ▸ | NPY2R | P49146 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11533230 | 0.94 | GAA (0.44) | GAATSHR | |
| SCHEMBL7510294 | 0.87 | CYP3A4 (0.42) | MAPK1GAATSHRALDH1A1 | |
| SCHEMBL272632 | 0.82 | CYP2D6 (0.32) | — | |
| SCHEMBL11533225 | 0.81 | GAA (0.44) | GAATSHR | |
| SCHEMBL11534823 | 0.81 | GAA (0.44) | GAATSHR | |
| SCHEMBL272466 | 0.81 | CHRM2 (0.35) | — | |
| SCHEMBL11533829 | 0.79 | TSHR (0.44) | GAATSHR | |
| SCHEMBL11530764 | 0.79 | GAA (0.42) | GAATSHR | |
| SCHEMBL11530462 | 0.78 | CHRM1 (0.35) | — | |
| SCHEMBL11532899 | 0.77 | GAA (0.41) | GAATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619050-B2 | Alkoxyamines containing a radically polymerizable group | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2009-11-17 | — | — | US | disclosed |
| EP-1749032-B1 | ALKOXYAMINES CONTAINING A RADICALLY POLYMERIZABLE GROUP | CIBA SC HOLDING AG (CH) | 2008-02-27 | — | — | EP | disclosed |
| US-20070232768-A1 | Alkoxyamines Containing a Radically Polymerizable Group | CIBA SPECIALTY CHEMICALS CORP. | 2007-10-04 | — | — | US | disclosed |
| EP-1749032-A1 | ALKOXYAMINES CONTAINING A RADICALLY POLYMERIZABLE GROUP | Ciba Geigy Specialty Chemicals Holding Inc. (CH) | 2007-02-07 | — | — | EP | disclosed |
| WO-2005118651-A1 | ALKOXYAMINES CONTAINING A RADICALLY POLYMERIZABLE GROUP | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232768-A1 | Alkoxyamines Containing a Radically Polymerizable Group | ALKBH3, ALKBH2, ALKBH5 | MAPK1 3823/4885GAA 4345/4885TSHR 3987/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.